SECTION27 intervenes in Aventis v Cipla on behalf of TAC
4 May 2012 The TAC National Council has resolved to seek admission in a legal dispute between the brand name drug company Aventis Pharma and the generic company Cipla, over a claim of patent infringement in respect of a drug that treats cancer called Docetaxel. SECTION27 is acting as attorneys Continue Reading